We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Michael Weisman MD

Michael Weisman MD

Retired Director of the Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California

Dr. Weisman is the recently retired Director of the Division of Rheumatology at Cedars-Sinai Medical Center. His academic and research interests for the past 40 years have centered on the genetic and environmental risks for outcome in chronic rheumatic diseases. His experiences over the decades included organization and implementation of large-scale outcome studies and clinical trials funded by industry, the NIH, the Veterans Administration, and multiple Foundations. These include experience as an investigator for National Institutes of Health sponsored outcome and clinical trial studies in systemic lupus erythematosus, osteoarthritis, ankylosing spondylitis, vasculitis, scleroderma, sudden sensory-neural hearing loss, and rheumatoid arthritis. Board certified in internal medicine and rheumatology, He has participated on agencies, review panels and advisory boards for numerous healthcare organizations, including the FDA Arthritis Advisory Committee, Veterans Administration Cooperative Studies Program, National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National Heart, Lung, and Blood Institute (NHLBI), Medical Board of California, Arthritis Foundation, American College of Rheumatology, Institute of Medicine (National Academy of Sciences) and National Board of Medical Examiners. My own work has been published in more than 475 peer-reviewed journals and I have edited 12 books in the field of Rheumatic Diseases; he is currently editing the newest (8th) edition of Rheumatology, the major international textbook in the field of rheumatic diseases.  Currently,he is the series editor of hRheumatic Diseases Clinics of North America.  In the last decade he was President of the Research and Education Foundation for the American College of Rheumatology.  He was recently cited and interviewed as a Master Clinician in the well-received series published by the ACR called “The Rheumatologist,” something for which he is particularly proud.  Finally, among the honors and awards that mean a great deal to him is the Excellence in Research Mentoring Award from the American College of Rheumatology, awarded in 2010.